Patent · US Active

Cyclopentaimidazolones for the treatment of cancer

US12152008B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignees

The Broad Institute, Inc. · US
DANA-FARBER CANCER INSTITUTE, INC. · US
President and Fellows of Harvard College · US

Inventors

Srivatsan Raghavan · Boston, US
Bruce Kuan-Yee Hua · Cambridge, US
Shubhroz Gill · Cambridge, US
Stuart L. Schreiber · Cambridge, US
William C. Hahn · Boston, US
Paul Clemons · Somerville, US
Raymond Ng · San Ramon, US
Partha P. Nag · Somerville, US

Key dates

Filing date	Sep 4, 2020
Grant date	Nov 26, 2024
Priority date	—
Expiry date	Jul 28, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds useful for the treatment of various proliferative diseases. These compounds, as well as pharmaceutically acceptable salts thereof may be formulated in pharmaceutical compositions, and may be used in methods of treatment and/or prophylaxis of proliferative diseases, including cancer, and more specifically, pancreatic cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.